Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

2012 Annual Report & Accounts and Notice of AGM

28th Jun 2013 16:08

RNS Number : 1899I
Sphere Medical Holding plc
28 June 2013
 



 

28 June 2013

 

Sphere Medical Holding plc

2012 Annual Report & Accounts and Notice of AGM

Cambridge, UK, 28 June 2013: Sphere Medical Holding plc (AIM: SPHR.L), a leading developer of innovative monitoring and diagnostic products for the critical care setting, announces that it has published its Annual Report and Accounts for the year ended 31 December 2012. The document is available on the Company's website: www.spheremedical.com.

Sphere Medical confirms that its Annual General Meeting will be held at 11.00 a.m. on Wednesday 28 August 2013 at Harston Mill, Harston, Cambridge CB22 7GG. The Annual General Meeting Notice will be set out in the Annual Report and Accounts which will be posted to shareholders shortly.

For further information, please contact:

 

Sphere Medical Holding plc

Tel: +44 (0)1223 875222

Dr Stuart Hendry, Chief Executive Officer

Matthew Hall, Chief Financial Officer

Peel Hunt LLP

Tel: +44 (0) 20 7418 8900

James Steel

Dr Vijay Barathan

M:Communications

Mary-Jane Elliott, Amber Bielecka, Hollie Vile

Tel: +44 (0) 20 7920 2333

[email protected]

 

About Sphere Medical

Sphere Medical (AIM: SPHR.L), is a medical device company developing a range of innovative monitoring and diagnostic devices designed to significantly improve patient care.

Sphere Medical's Proxima and Cardiopulmonary Bypass devices deliver real time analysis of blood gases, electrolytes, glucose and drug levels with laboratory accuracy, at the patient's bedside. Globally over 240 million blood gas and electrolyte tests are carried out on patients every year in critical care and there is an unmet need for monitoring products that are small, simple to use and cost effective with improved functionality. Sphere Medical's products can be used in a wide range of medical applications enabling faster clinical decision making and consequently improved patient outcomes, whilst also reducing costs for healthcare payers.

Sphere Medical is headquartered in Cambridge, UK and employs around 60 people. The Company has existing commercial partnerships with the leading global medical device companies. For further information, please visit www.spheremedical.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSBUGDLRGDBGXI

Related Shares:

Sphere Medical Holding
FTSE 100 Latest
Value8,415.25
Change0.00